Fastest
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →https://eureka.patsnap.com/resources/blog/rd-blog/spatial-omics-bead-array-positional-barcode-decoding-patent-landscape-patent-landscape/ · Patsnap · data cut-off 2026-08-31 · downloaded from the live page
Patent Landscape BriefSpatial Omics Bead Array Positional Barcode Decoding Patents
A data-driven look at spatial omics bead array positional barcode decoding patents: a concentrated leader, a 2023 filing peak, and the under-claimed material-analysis branch, based on 16 published records through 2026.
16
Published Records
-50%
Filing Growth 2021→2024
US
Leading Jurisdiction
2023
Peak Filing Year
Filing growth = 2021 (2 records) → 2024 (1); 2024 is the last year we treat as complete.
Published byPatsnap Research··5 min readSourced from Patsnap Eureka
Landscape Overview
What this patent set covers
This landscape tracks published patent families matching spatial omics and spatial transcriptomics bead array or bead-based array methods where barcoding or decoding of positional identity is claimed. It is a small, specialised corpus — 16 published records as of the 2026-08-31 data cut-off — concentrated around enzymatic DNA library-preparation methods and combinatorial bead-array chemistry.
Because family counts are the fairer comparison unit than raw document counts, and because this dataset already reports at the family level, the 16-record total and the four-assignee ranking below both describe the same underlying set of technical positions, not an inflated document count.
Records in scope by filing year
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Spatial Omics Bead Array Positional Barcode Decoding Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
10,000 free credits to start
Filing Data
Filing trends and technology composition
The filing trend and IPC composition below are drawn from the 16 published records currently in scope for this search string.
Filings rose to a 2023 peak, then the count declines into partial recent years
Filings moved from 2 in 2021 to a peak of 10 in 2023, then dropped to 1 by 2024 — a 2021-to-2024 change of -50%. Because publication lags filing by roughly 18 months, 2025 and 2026 are still filling in and should not be read as a real slowdown yet.
Publication lags filing by roughly 18 months, so 2025 onwards are still filling in. Growth rates on this page therefore end at 2024; running them to the last bar would understate the field.
Enzymatic DNA methods and combinatorial libraries dominate the claim space
C12Q (measuring/testing involving enzymes or DNA) appears in 93.8% of the 16 records and C12N (microorganisms and genetic engineering) in 75.0%, meaning most filings combine the two. C40B (combinatorial chemistry libraries) reaches 37.5%, while G01N (material analysis and testing) is present in only 12.5% — the thinnest-claimed branch in this set.
Shares are the percentage of the 16 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Spatial Omics Bead Array Positional Barcode Decoding Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.
Go deeper on Spatial Omics Bead Array Positional Barcode Decoding Patent Landscape with Eureka
This page is one run against one query. Ask Eureka your own question about spatial omics bead array positional barcode decoding patent landscape and every answer comes back with the patent numbers behind it.
Try EurekaRepresentative Filing
A recent filing that shows where library-prep claims are heading
Filed 2025-12-04
Spatial transcriptomics library preparation materials and methods
ILLUMINA, INC.
Methods for improving preparation of a spatial transcriptomics RNA library, such as an mRNA library, by improving capture of RNA transcript information from a tissue sample in situ. The resulting library supports genetic profiling to help diagnose conditions such as cancer, genetic disease and autoimmune disease, and to improve treatment.Filed by ILLUMINA, INC. — published as US20250369156A1.
Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Spatial Omics Bead Array Positional Barcode Decoding Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself
Put your own technology through the same analysis
Where to run it
For builders
MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Landscape Signals
What the filing data tells you
Four figures worth acting on before drafting a claim or scoping a freedom-to-operate review in this space.
Concentration
13 of 16 records
leader's filing share
One assignee dominates a small field
Against three other ranked assignees, one company holds 13 of the 16 records tracked in this dataset. That is not a percentage of a large universe — it is the leader's position inside a genuinely small, specialised filing set.
Assignee ranking, 4 companies
Filing momentum
-50%
2021 to 2024 change
Peak passed in 2023, then a sharp drop
Filings ran 2 in 2021 up to 10 in 2023, then down to 1 by 2024. The -50% change covers only the complete years; 2025-2026 are still filling in given the usual 18-month publication lag.
Filing trend, 2021-2026
Technology mix
93.8%
of 16 records carry C12Q
Enzymatic DNA methods anchor almost every filing
C12Q appears in 93.8% of records and C12N in 75.0%, meaning most filings stack enzymatic and genetic-engineering claims together rather than picking one or the other.
IPC composition, 16 records
White space
12.5%
of 16 records carry G01N
Material-analysis verification is barely claimed
Only 2 of the 16 records touch G01N-style material analysis and testing, the thinnest branch of the four IPC subclasses tracked here — a candidate area for a first-mover claim.
IPC composition, 16 records
Eureka AI Agent
Looking for what nobody has claimed yet?
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to spatial omics bead array positional barcode decoding patent landscape, with the prior art for and against each one.
Source: Patsnap Eureka. Derived observations on the same dataset. Derived from a Patsnap search on Spatial Omics Bead Array Positional Barcode Decoding Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Next Steps
Where to take this analysis next
The filing data points to a concentrated leader and a thin material-analysis branch — both are starting points for deeper claim-level work.
Map the leader's full claim scope
With 13 of 16 records held by one assignee, a claim-by-claim read of that portfolio is the fastest way to see exactly which library-prep and decoding steps are already locked up.
Explore assignee filings in EurekaTest the G01N white space
Material-analysis verification of positional decoding sits in only 2 of 16 records. Drafting a first claim there needs a check against adjacent instrumentation patents outside this search string.
Run a white-space search in EurekaWatch the 2025-2026 filings as they publish
The current trend understates recent activity because of the standard 18-month publication lag. Re-checking this set in the next filing cycle will show whether the 2023 peak was a one-off or the start of a new wave.
Set a filing alert in EurekaSource: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Spatial Omics Bead Array Positional Barcode Decoding Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Frequently Asked
Questions practitioners ask about this landscape
Within the 16-record dataset tracked for this search string, one assignee holds 13 filings — a clear leader against three other ranked assignees. That concentration means most of the claimed chemistry around bead-array decoding sits with a single organisation rather than being spread across the field. Anyone assessing freedom to operate should start by mapping their own workflow steps against that leader's filings before looking at the smaller players.
Filings rose from 2 in 2021 to a peak of 10 in 2023, then fell to 1 by 2024, a -50% change over that three-year span. Because patent publication typically lags actual filing by around 18 months, the 2025 and 2026 figures in this dataset are still incomplete and should not be read as an active slowdown. The honest read is that 2023 marked a filing peak and the true 2025-2026 trend will not be clear for another year or two.
C12Q, covering enzyme- and DNA-based measuring and testing methods, appears in 93.8% of the 16 records in scope, and C12N, covering genetic engineering methods, appears in 75.0%. Combinatorial chemistry library methods under C40B reach 37.5%, while material-analysis methods under G01N are present in just 12.5% of records. Since a single record can carry multiple IPC classes, these figures overlap rather than sum to 100%.
US20250369156A1, filed by Illumina and published 2025-12-04, covers methods and materials for improving spatial transcriptomics library preparation, specifically improving capture of RNA transcript information from a tissue sample in situ. The stated application is building a genetic profile from a tissue sample useful for diagnosing conditions such as cancer or autoimmune disease. It is a library-preparation improvement rather than a positional-decoding-algorithm claim, so its practical scope is narrower than the filing's broad diagnostic framing suggests.
G01N, material analysis and testing, is present in only 12.5% of the 16 records in this dataset, making it the thinnest-claimed of the four IPC subclasses tracked here. That suggests analytical or instrumentation-based verification of positional barcode decoding — as distinct from the enzymatic or combinatorial-library chemistry that dominates the rest of the set — is comparatively open. Given the small total record count, this gap could close quickly once a well-resourced filer moves into it.
Answers are grounded in the same dataset. Derived from a Patsnap search on Spatial Omics Bead Array Positional Barcode Decoding Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Research Spatial Omics Bead Array Positional Barcode Decoding Patent Landscape in depth with Eureka
Go past this page: query the whole spatial omics bead array positional barcode decoding patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.